$6.89 Billion is the total value of Bellevue Group AG's 202 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $360,974,124 | +14.0% | 1,145,695 | +4.5% | 5.24% | +24.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $247,495,759 | -2.5% | 968,786 | +1.2% | 3.59% | +6.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $129,656,400 | +14.5% | 3,090,000 | +4.1% | 1.88% | +25.1% |
| AXNX | Buy | AXONICS INC | $104,311,136 | -12.5% | 1,911,861 | +0.3% | 1.51% | -4.3% |
| MDT | Buy | MEDTRONIC PLC | $99,100,926 | +106.2% | 1,229,235 | +98.8% | 1.44% | +125.4% |
| BDX | Buy | BECTON DICKINSON & CO | $86,154,564 | +2.2% | 348,043 | +5.0% | 1.25% | +11.7% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $81,362,308 | +53.5% | 7,026,106 | +8.4% | 1.18% | +68.0% |
| OPCH | Buy | OPTION CARE HEALTH INC | $77,588,217 | +6.1% | 2,442,185 | +0.5% | 1.13% | +16.0% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $73,174,837 | +28.2% | 1,109,382 | +0.5% | 1.06% | +40.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $72,844,716 | -9.5% | 1,793,763 | +0.1% | 1.06% | -1.1% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $71,102,720 | +27.7% | 2,191,147 | +10.5% | 1.03% | +39.6% |
| MGNX | Buy | MACROGENICS INC | $68,903,077 | +14.4% | 9,609,913 | +7.0% | 1.00% | +25.0% |
| PEN | Buy | PENUMBRA INC | $66,376,155 | +32.1% | 238,172 | +5.5% | 0.96% | +44.4% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $61,039,652 | -3.4% | 302,446 | +4.3% | 0.89% | +5.6% |
| SWAV | Buy | SHOCKWAVE MED INC | $61,010,758 | +19.8% | 281,376 | +13.6% | 0.88% | +30.9% |
| ACCD | Buy | ACCOLADE INC | $58,121,099 | +102.9% | 4,041,801 | +9.9% | 0.84% | +121.8% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $57,184,720 | +242.4% | 171,140 | +116.1% | 0.83% | +273.9% |
| INSM | Buy | INSMED INC | $56,147,389 | -14.3% | 3,293,102 | +0.5% | 0.82% | -6.2% |
| IDXX | Buy | IDEXX LABS INC | $55,472,874 | +25.0% | 110,928 | +1.9% | 0.80% | +36.7% |
| BIO | Buy | BIO RAD LABS INCcl a | $54,483,256 | +16.6% | 113,739 | +2.3% | 0.79% | +27.6% |
| OM | Buy | OUTSET MED INC | $53,484,366 | -27.2% | 2,906,759 | +2.2% | 0.78% | -20.3% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $49,759,751 | +8.4% | 86,333 | +3.6% | 0.72% | +18.6% |
| VEEV | Buy | VEEVA SYS INC | $48,334,013 | +60.8% | 262,985 | +41.2% | 0.70% | +75.7% |
| SILK | Buy | SILK RD MED INC | $41,858,887 | -21.8% | 1,069,739 | +5.7% | 0.61% | -14.5% |
| CDNA | Buy | CAREDX INC | $31,433,292 | -13.1% | 3,439,091 | +8.5% | 0.46% | -5.0% |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $27,683,001 | +35.3% | 1,002,644 | +11.3% | 0.40% | +48.3% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $27,222,468 | -19.2% | 441,350 | +1.1% | 0.40% | -11.6% |
| ATRC | Buy | ATRICURE INC | $26,827,352 | -6.2% | 647,222 | +0.5% | 0.39% | +2.6% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $24,459,788 | +38.1% | 507,254 | +43.0% | 0.36% | +51.1% |
| HCM | Buy | HUTCHMED CHINA LTDsponsored ads | $23,787,149 | -16.3% | 1,826,970 | +2.6% | 0.34% | -8.5% |
| HOLX | Buy | HOLOGIC INC | $23,413,975 | +28.7% | 290,136 | +19.3% | 0.34% | +41.1% |
| ILMN | Buy | ILLUMINA INC | $23,082,215 | +20.3% | 99,257 | +4.6% | 0.34% | +31.4% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $21,558,508 | -3.0% | 948,878 | +0.5% | 0.31% | +6.1% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $19,526,202 | -40.6% | 598,046 | +0.3% | 0.28% | -35.1% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $17,671,434 | -29.6% | 4,299,619 | +0.4% | 0.26% | -23.1% |
| NTRA | Buy | NATERA INC | $12,923,668 | +85.1% | 232,775 | +33.9% | 0.19% | +102.2% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $12,551,390 | +62.7% | 58,235 | +68.8% | 0.18% | +78.4% |
| TDOC | Buy | TELADOC HEALTH INC | $11,207,474 | +21.4% | 432,721 | +10.9% | 0.16% | +32.5% |
| ZLAB | Buy | ZAI LAB LTDadr | $5,301,644 | +86.8% | 159,400 | +77.1% | 0.08% | +102.6% |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $5,274,675 | – | 262,683 | +100.0% | 0.08% | – |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $4,969,756 | +6.9% | 71,600 | +4.5% | 0.07% | +16.1% |
| SGEN | Buy | SEAGEN INC | $4,596,069 | +58.1% | 22,700 | +0.3% | 0.07% | +71.8% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $4,451,979 | +12.4% | 122,881 | +10.7% | 0.06% | +22.6% |
| ABBV | Buy | ABBVIE INC | $2,737,339 | +4.6% | 17,176 | +6.0% | 0.04% | +14.3% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $2,547,350 | +50.6% | 15,910 | +55.8% | 0.04% | +68.2% |
| ALKS | Buy | ALKERMES PLC | $1,809,798 | +14.5% | 64,200 | +80.8% | 0.03% | +23.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $1,603,187 | +104.4% | 6,988 | +109.8% | 0.02% | +130.0% |
| BBIO | New | BRIDGEBIO PHARMA INC | $1,369,508 | – | 82,600 | +100.0% | 0.02% | – |
| ISEE | Buy | IVERIC BIO INC | $1,287,057 | +43.8% | 52,900 | +26.6% | 0.02% | +58.3% |
| ETNB | New | 89BIO INC | $1,020,410 | – | 67,000 | +100.0% | 0.02% | – |
| GDX | Buy | VANECK ETF TRUSTgold miners etf | $1,067,550 | +102.4% | 33,000 | +79.3% | 0.02% | +114.3% |
| New | VENTYX BIOSCIENCES INC | $854,250 | – | 25,500 | +100.0% | 0.01% | – | |
| MRK | Buy | MERCK & CO INC | $752,709 | +0.5% | 7,075 | +4.8% | 0.01% | +10.0% |
| ZTS | New | ZOETIS INCcl a | $228,522 | – | 1,373 | +100.0% | 0.00% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $123,088 | – | 870 | +100.0% | 0.00% | – |
| HSIC | New | HENRY SCHEIN INC | $85,046 | – | 1,043 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.